AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-79
Results: 1-25/79
REVERSAL OF HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E2 AND APOLIPOPROTEIN E3-LEIDEN TRANSGENIC MICE BY ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE VLDL RECEPTOR
Authors: VANDIJK KW VANVLIJMEN BJM VANDERZEE A VANTHOF B VANDERBOOM H KOBAYASHI K CHAN L HAVEKES LM HOFKER MH
Citation: Kw. Vandijk et al., REVERSAL OF HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E2 AND APOLIPOPROTEIN E3-LEIDEN TRANSGENIC MICE BY ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE VLDL RECEPTOR, Arteriosclerosis, thrombosis, and vascular biology, 18(1), 1998, pp. 7-12
EFFECTS OF DIETARY FISH-OIL ON SERUM-LIPIDS AND VLDL KINETICS IN HYPERLIPIDEMIC APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE
Authors: VANVLIJMEN BJM MENSINK RP VANTHOF HB OFFERMANS RFG HOFKER MH HAVEKES LM
Citation: Bjm. Vanvlijmen et al., EFFECTS OF DIETARY FISH-OIL ON SERUM-LIPIDS AND VLDL KINETICS IN HYPERLIPIDEMIC APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE, Journal of lipid research, 39(6), 1998, pp. 1181-1188
HYPERLIPIDEMIA AND CUTANEOUS ABNORMALITIES IN TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1
Authors: JONG MC GIJBELS MJJ DAHLMANS VEH VANGORP PJJ KOOPMAN SJ PONEC M HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., HYPERLIPIDEMIA AND CUTANEOUS ABNORMALITIES IN TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1, The Journal of clinical investigation, 101(1), 1998, pp. 145-152
TRANSGENIC MOUSE MODELS TO STUDY THE ROLE OF APOE IN HYPERLIPIDEMIA AND ATHEROSCLEROSIS
Authors: HOFKER MH VANVLIJMEN BJM HAVEKES LM
Citation: Mh. Hofker et al., TRANSGENIC MOUSE MODELS TO STUDY THE ROLE OF APOE IN HYPERLIPIDEMIA AND ATHEROSCLEROSIS, Atherosclerosis, 137(1), 1998, pp. 1-11
CHARACTERIZATION OF ATHEROSCLEROTIC LESIONS IN APO E3-LEIDEN TRANSGENIC MICE
Authors: LEPPANEN P LUOMA JS HOFKER MH HAVEKES LM YLAHERTTUALA S
Citation: P. Leppanen et al., CHARACTERIZATION OF ATHEROSCLEROTIC LESIONS IN APO E3-LEIDEN TRANSGENIC MICE, Atherosclerosis, 136(1), 1998, pp. 147-152
TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1 ARE HYPERLIPIDEMIC AND SHOW AN INCREASE IN INSULIN-MEDIATED GLUCOSE-METABOLISM
Authors: KOOPMANS SJ JONG MC QUE I DAHLMANS VEH PETRONILIA HD RADDER JK HOFKER MH HAVEKES LM
Citation: Sj. Koopmans et al., TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1 ARE HYPERLIPIDEMIC AND SHOW AN INCREASE IN INSULIN-MEDIATED GLUCOSE-METABOLISM, Diabetologia, 41, 1998, pp. 297-297
IN THE ABSENCE OF THE LDL RECEPTOR, ONLY A NARROW RANGE OF HEPATIC APOE EXPRESSION REDUCES HYPERLIPIDEMIA IN APOE DEFICIENT MICE
Authors: VANVLIJMEN BJ VANDIJK KW VANTHOF BH VANDERZEE A SANTAMARINAFOJO S VANBERKEL TJ HAVEKES LM HOFKER MH
Citation: Bj. Vanvlijmen et al., IN THE ABSENCE OF THE LDL RECEPTOR, ONLY A NARROW RANGE OF HEPATIC APOE EXPRESSION REDUCES HYPERLIPIDEMIA IN APOE DEFICIENT MICE, Circulation, 98(17), 1998, pp. 164-164
DIFFERENTIAL-EFFECTS OF ABSENCE OF APOC3, APOC1 AND APOE ON POSTPRANDIAL TRIGLYCERIDE-METABOLISM
Authors: JONG MC DAHLMANS VEH HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., DIFFERENTIAL-EFFECTS OF ABSENCE OF APOC3, APOC1 AND APOE ON POSTPRANDIAL TRIGLYCERIDE-METABOLISM, Circulation, 98(17), 1998, pp. 2438-2438
MACROPHAGE SPECIFIC OVEREXPRESSION OF THE HUMAN MACROPHAGE SCAVENGER RECEPTOR IN TRANSGENIC MICE, USING A 180 KB YEAST ARTIFICIAL CHROMOSOME, LEADS TO ENHANCED FOAM CELL-FORMATION OF ISOLATED PERITONEAL-MACROPHAGES
Authors: DEWINTHER MPJ VANDIJK KW VANVLIJMEN BJM GIJBELS MJJ WIJERS ER BREUER M FRANTS RR HAVEKES LM HOFKER MH
Citation: Mpj. Dewinther et al., MACROPHAGE SPECIFIC OVEREXPRESSION OF THE HUMAN MACROPHAGE SCAVENGER RECEPTOR IN TRANSGENIC MICE, USING A 180 KB YEAST ARTIFICIAL CHROMOSOME, LEADS TO ENHANCED FOAM CELL-FORMATION OF ISOLATED PERITONEAL-MACROPHAGES, Circulation, 98(17), 1998, pp. 2441-2441
EXCESS OF APOLIPOPROTEIN C1 ON THE VLDL PARTICLE IMPAIRS FREE FATTY-ACID UPTAKE IN TISSUES
Authors: JONG MC KOOPMANS SJ DAHLMANS VEH RADDER JK HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., EXCESS OF APOLIPOPROTEIN C1 ON THE VLDL PARTICLE IMPAIRS FREE FATTY-ACID UPTAKE IN TISSUES, Circulation, 98(17), 1998, pp. 2442-2442
ADENOVIRUS-MEDIATED GENE-TRANSFER OF APOLIPOPROTEIN E2 (LYS146-]GLN) IN APOLIPOPROTEIN-E KNOCKOUT MICE CAUSES HYPERTRIGLYCERIDEMIA DUE TO AN IMPAIRED LIPOLYSIS OF VERY-LOW-DENSITY LIPOPROTEINS
Authors: DEBEER F VANDIJK KW JONG MC KAMERLING SWA DAHLMANS VEH VANDERZEE A SMELT AHM HOFKER MH HAVEKES LM
Citation: F. Debeer et al., ADENOVIRUS-MEDIATED GENE-TRANSFER OF APOLIPOPROTEIN E2 (LYS146-]GLN) IN APOLIPOPROTEIN-E KNOCKOUT MICE CAUSES HYPERTRIGLYCERIDEMIA DUE TO AN IMPAIRED LIPOLYSIS OF VERY-LOW-DENSITY LIPOPROTEINS, Circulation, 98(17), 1998, pp. 2774-2774
TOWARDS IDENTIFICATION OF NEW GENES MODIFYING PLASMA-LIPID LEVELS ANDSUSCEPTIBILITY TO ATHEROSCLEROSIS
Authors: MOEN CJA VANGORP PJJ GIJBELS MJJ DEKRAKER J FRANTS RR HOFKER MH
Citation: Cja. Moen et al., TOWARDS IDENTIFICATION OF NEW GENES MODIFYING PLASMA-LIPID LEVELS ANDSUSCEPTIBILITY TO ATHEROSCLEROSIS, Circulation, 98(17), 1998, pp. 2797-2797
APOLIPOPROTEIN E-ASTERISK-3 LEIDEN TRANSGENIC MICE AS A TEST MODEL FOR HYPOLIPEMIC DRUGS
Authors: VANVLIJMEN BJM PEARCE NJ BERGO M STAELS B YATES JW GRIBBLE AD BOND BC HOFKER MH HAVEKES LM GROOT PHE
Citation: Bjm. Vanvlijmen et al., APOLIPOPROTEIN E-ASTERISK-3 LEIDEN TRANSGENIC MICE AS A TEST MODEL FOR HYPOLIPEMIC DRUGS, Arzneimittel-Forschung, 48(4), 1998, pp. 396-402
UPTAKE BY J774 MACROPHAGES OF VERY-LOW-DENSITY LIPOPROTEINS ISOLATED FROM APOE-DEFICIENT MICE IS MEDIATED BY A DISTINCT RECEPTOR AND STIMULATED BY LIPOPROTEIN-LIPASE
Authors: HENDRIKS WL VANDERSMANDEBEER F VANVLIJMEN BJM VANVARK LC HOFKER MH HAVEKES LM
Citation: Wl. Hendriks et al., UPTAKE BY J774 MACROPHAGES OF VERY-LOW-DENSITY LIPOPROTEINS ISOLATED FROM APOE-DEFICIENT MICE IS MEDIATED BY A DISTINCT RECEPTOR AND STIMULATED BY LIPOPROTEIN-LIPASE, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 498-504
USE OF TRANSGENIC MICE IN LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS RESEARCH
Authors: HAVEKES LM VANVLIJMEN BJM JONG MC VANDIJK KW HOFKER MH
Citation: Lm. Havekes et al., USE OF TRANSGENIC MICE IN LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS RESEARCH, Prostaglandins, leukotrienes and essential fatty acids, 57(4-5), 1997, pp. 463-466
NASCENT VERY-LOW-DENSITY LIPOPROTEIN TRIACYLGLYCEROL HYDROLYSIS BY LIPOPROTEIN-LIPASE IS INHIBITED BY APOLIPOPROTEIN-E IN A DOSE-DEPENDENT MANNER
Authors: JONG MC DAHLMANS VEH HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., NASCENT VERY-LOW-DENSITY LIPOPROTEIN TRIACYLGLYCEROL HYDROLYSIS BY LIPOPROTEIN-LIPASE IS INHIBITED BY APOLIPOPROTEIN-E IN A DOSE-DEPENDENT MANNER, Biochemical journal, 328, 1997, pp. 745-750
REDUCED VERY-LOW-DENSITY LIPOPROTEIN FRACTIONAL CATABOLIC RATE IN APOLIPOPROTEIN C1-DEFICIENT MICE
Authors: JONG MC VANREE JH DAHLMANS VEH FRANTS RR HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., REDUCED VERY-LOW-DENSITY LIPOPROTEIN FRACTIONAL CATABOLIC RATE IN APOLIPOPROTEIN C1-DEFICIENT MICE, Biochemical journal, 321, 1997, pp. 445-450
SUBTELOMERIC EXCHANGE OF 3.3. KB REPEATS BETWEEN CHROMOSOMES 4Q35 AND10Q26 IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY - IMPLICATIONS FOR COUNSELING AND ETIOLOGY
Authors: PADBERG GW VANDEUTEKOM JC BAKKER E VANDERWIELEN MJR BIK EJ HOFKER MH FRANTS RR
Citation: Gw. Padberg et al., SUBTELOMERIC EXCHANGE OF 3.3. KB REPEATS BETWEEN CHROMOSOMES 4Q35 AND10Q26 IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY - IMPLICATIONS FOR COUNSELING AND ETIOLOGY, Neurology, 48(3), 1997, pp. 21001-21001
IMPAIRED SECRETION OF VERY-LOW-DENSITY-LIPOPROTEIN TRIGLYCERIDES BY APOLIPOPROTEIN-E DEFICIENT MOUSE HEPATOCYTES
Authors: KUIPERS F JONG MC LIN YG VANECK M HAVINGA R BLOKS V VERKADE HJ HOFKER MH MOSHAGE H VANBERKEL TJC VONK RJ HAVEKES LM
Citation: F. Kuipers et al., IMPAIRED SECRETION OF VERY-LOW-DENSITY-LIPOPROTEIN TRIGLYCERIDES BY APOLIPOPROTEIN-E DEFICIENT MOUSE HEPATOCYTES, The Journal of clinical investigation, 100(11), 1997, pp. 2915-2922
ATHEROSCLEROSIS IN SCAVENGER RECEPTOR-DEFICIENT APOE3LEIDEN TRANSGENIC MICE
Authors: DEWINTHER MPJ GIJBELS MJJ VANDIJK KW VANGORP PJJ KODAMA T FRANTS RR HAVEKES LM HOFKER MH
Citation: Mpj. Dewinther et al., ATHEROSCLEROSIS IN SCAVENGER RECEPTOR-DEFICIENT APOE3LEIDEN TRANSGENIC MICE, Atherosclerosis, 134(1-2), 1997, pp. 33-33
LIPOPROTEIN METABOLISM IN MICE FOLLOWING ADENOVIRUS-MEDIATED TRANSFEROF THE HUMAN PHOSPHOLIPID TRANSFER PROTEIN GENE
Authors: EHNHOLM S VANDIJK KW VANDERZEE A VANTHOF BH HOFKER MH HAVEKES LM JAUHIAINEN M OLKKONEN V EHNHOLM C
Citation: S. Ehnholm et al., LIPOPROTEIN METABOLISM IN MICE FOLLOWING ADENOVIRUS-MEDIATED TRANSFEROF THE HUMAN PHOSPHOLIPID TRANSFER PROTEIN GENE, Atherosclerosis, 134(1-2), 1997, pp. 34-34
THE EFFECTS OF DIETARY FISH-OIL ON SERUM-LIPIDS AND VERY-LOW-DENSITY LIPOPROTEIN-KINETICS IN HYPERLIPIDEMIC APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE
Authors: VANVLIJMEN BJM MENSINK RP VANTHOF HB OFFERMANS RFG HOFKER MH HAVEKES LM
Citation: Bjm. Vanvlijmen et al., THE EFFECTS OF DIETARY FISH-OIL ON SERUM-LIPIDS AND VERY-LOW-DENSITY LIPOPROTEIN-KINETICS IN HYPERLIPIDEMIC APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE, Atherosclerosis, 134(1-2), 1997, pp. 40-40
OVEREXPRESSION OF APOC1 AND APOE VARIANTS IN TRANSGENIC MICE MODULATES BINDING OF VLDL TO LRP, LDL RECEPTOR AND VLDL RECEPTOR
Authors: HAVEKES LM JONG MC VANVLIJMEN BJM VANDJIK KW HOFKER MH
Citation: Lm. Havekes et al., OVEREXPRESSION OF APOC1 AND APOE VARIANTS IN TRANSGENIC MICE MODULATES BINDING OF VLDL TO LRP, LDL RECEPTOR AND VLDL RECEPTOR, Atherosclerosis, 134(1-2), 1997, pp. 290-290
THE PROGRESSION AND REGRESSION OF ATHEROSCLEROSIS IN APOE3LEIDEN TRANSGENIC MICE - AN IMMUNOHISTOCHEMICAL STUDY
Authors: GIJBELS MJJ VANDERCAMMEN M VANDERLAAN L EMEIS JJ HAVEKES LM HOFKER MH KRAAL G
Citation: Mjj. Gijbels et al., THE PROGRESSION AND REGRESSION OF ATHEROSCLEROSIS IN APOE3LEIDEN TRANSGENIC MICE - AN IMMUNOHISTOCHEMICAL STUDY, Atherosclerosis, 134(1-2), 1997, pp. 297-297
THE BINDING OF VERY-LOW-DENSITY LIPOPROTEINS (VLDL) TO THE VLDL RECEPTOR IS INHIBITED BY APOLIPOPROTEIN (APO) C1
Authors: JONG MC DAHLMANS VEH VANGORP PJJ VANDIJK KW HOFKER MH HAVEKES LM
Citation: Mc. Jong et al., THE BINDING OF VERY-LOW-DENSITY LIPOPROTEINS (VLDL) TO THE VLDL RECEPTOR IS INHIBITED BY APOLIPOPROTEIN (APO) C1, Atherosclerosis, 134(1-2), 1997, pp. 358-358
Risultati: 1-25 | 26-50 | 51-75 | 76-79